Page 65 - ESHRE2019
P. 65
Clinical pregnancy rate
Menevit Mg
VitE
Zinc N‐Ac‐Cys
Zinc + folic acid Folic acid
5.9%
OD=3.43 [1.92‐6.11]
16.6%
Tremellen K, Miari G, Froiland D, Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Aust N Z J Obstet Gynaecol. 2007 Jun;47(3):216-21.
Antioxidant: 38.5% ongoing pregnancy at 13 weeks Placebo : 16% ongoing pregnancy at 13 weeks
59
PRECONGRESS COURSE 01 I VIENNA, AUSTRIA – 23 JUNE 2019 63
